HC Wainwright & Co. Reiterates Buy on Affimed, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a Buy rating on Affimed (NASDAQ:AFMD) and maintained a $5 price target on the stock.

November 15, 2023 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst reaffirms a Buy rating and a $5 price target for Affimed, indicating a positive outlook for the stock.
The reiteration of a Buy rating and maintenance of a price target by a reputable analyst can instill confidence in investors and potentially lead to a short-term increase in the stock price. The specific mention of Affimed and the maintained price target suggest a strong belief in the company's value proposition and future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100